By purchasing our forecast for THERMO FISHER SCIENTIFIC INC. (TMO), you can gain valuable insights into the changes in its cost in the coming months of December 2024, January 2025, February 2025, March 2025, and April 2025. This information is highly beneficial for earning and diversifying your portfolio. Our forecast will provide you with a clear understanding of whether the cost of TMO will rise or fall during these months, allowing you to make informed investment decisions. With this knowledge, you can strategically plan your investment approach and maximize your returns. Stay updated with our new forecasts to stay informed throughout the entire investment period.
Thermo Fisher Scientific Inc. (TMO) has been making waves in the market lately due to its impressive performance....
Thermo Fisher Scientific Inc. (TMO) recently announced the appointment of Michael Boxer as its new Senior Vice President and General Counsel....
Thermo Fisher Scientific Inc. (NYSE: TMO) has been attracting the attention of market whales with their recent bullish bets on TMO options....
Thermo Fisher Scientific, a leading global corporation specializing in scientific research and laboratory equipment, has made a significant move to expand its portfolio with the acquisition of Solventum's Filtration division. The deal, valued at $4.1 billion, will further enhance Thermo Fisher's position in the purification and filtration market. Solventum, a renowned player in the filtration indu...
Solventum, a leading provider of purification filtration solutions, has announced the sale of its business to Thermo Fisher Scientific Inc. for a staggering amount of 4.1 billion dollars....
Thermo Fisher Scientific Inc. (TMO), a leading scientific instruments company, has recently announced the appointment of Karen Lynch, former CEO of CVS Health, as a new director to its board....
Thermo Fisher Scientific Inc. (NYSE: TMO), a leading company in the field of scientific research, has appointed Karen Lynch, the former CEO of CVS Health, as a new director on its board....
Thermo Fisher Scientific Inc. (NYSE: TMO) has recently unveiled its latest innovative medical device, revolutionizing the healthcare industry....
Thermo Fisher Scientific Inc. TMO, a leading life sciences company, has announced the expansion of its medical device portfolio, positioning itself as a strong contender in the industry....
Thermo Fisher Scientific Inc. (NYSE:TMO) has released its financial report for the full year of 2024, surpassing market expectations....
Thermo Fisher Scientific Inc, a global leader in scientific research and laboratory equipment, announced a groundbreaking solar power agreement with X-ELIO....
Thermo Fisher Scientific Inc. recently announced a major solar power agreement with X-ELIO, a leader in the renewable energy sector....
Thermo Fisher Scientific Inc. (TMO) has reported its fourth quarter and full year 2024 results, surpassing expectations with strong revenue growth and increased earnings per share (EPS)....
Thermo Fisher Scientific Inc., a leading healthcare company, has reported impressive financial results for the fourth quarter and full year of 2024. With a revenue of $11....
Thermo Fisher Scientific Inc., a leading global healthcare company, continues to make strides in advancing the healthcare industry with its innovative solutions....
Thermo Fisher Scientific Inc. (NYSE: TMO), a leading provider of scientific research equipment and services, has been selected to contribute to the world's largest study on human proteomics....
Thermo Fisher Scientific's Olink platform has been chosen for the world's largest human proteomics study, marking a significant milestone for the company....
Thermo Fisher Scientific Inc. (NYSE:TMO) recently held its Q4 2024 earnings call on January 30, 2025, revealing outstanding financial results....
Thermo Fisher Scientific Inc. (NYSE:TMO) is a renowned global company that specializes in offering innovative solutions in the field of scientific research and healthcare....
Thermo Fisher Scientific Inc. (NYSE:TMO) has emerged as the top contender in the highly competitive field of CRISPR technology....
Stock ticker: | TMO |
Name: | THERMO FISHER SCIENTIFIC INC. |
Sector: | Healthcare |
Investing Risk: | HIGH |
Forecast length: | 15 days |
Accuracy: | 48.68 % |
Average profit per target: | 4.7 % |